SV1898 Talks - 刘诚:肿瘤免疫治疗的“淘金浪潮”

Actions and Detail Panel

Sales Ended

Event Information

Share this event

Date and time

Location

Location

SV 1898 Group, Inc.

4699 Old Ironsides Drive

Suite 150

Santa Clara, CA 95054

View Map

Event description

Description

刘诚博士是Eureka公司创始人兼CEO。成立Eureka之前,他是抗体药物研发Chiron公司(现在诺华公司)的一位首席科学家,在那里,他领导了anti-CSF1抗体治疗骨转移的人体临床试验项目。他是多个药物发现专利的发明者。2007年,因为改善人类健康做出的贡献,他被授予美国国会特别认可。刘博士北京大学获得细胞生物和遗传学学士学位,在加州大学伯克利分校获得分子细胞生物学博士学位。

刘诚博士将与我们分享:

1)对当前癌症免疫治疗的冷静分析;

2)投资生物医药领域的机会和风险;

3)作为一个留学生在美国创业的苦和乐。

Dr. Cheng Liu is the founder and CEO of Eureka Therapeutics, a California biotech company dedicated to antibody research and discovery for cancer immunotherapy. Prior to founding Eureka, Dr. Liu was a Principal Scientist in antibody drug discovery at Chiron (now Novartis), where he championed anti-CSF1 antibody program for treatment of bone metastasis to human clinical trials. He is the inventor of multiple issued US patents in drug discovery. In 2007, he was awarded Special US Congressional Recognition for his contributions to improving human health. Dr. Liu received his B.S. in Cell Biology and Genetics from PKU and a Ph.D in Molecular Cell Biology from UC Berkeley.



Date and time

Location

SV 1898 Group, Inc.

4699 Old Ironsides Drive

Suite 150

Santa Clara, CA 95054

View Map

Organizer SV 1898 Group, Inc

Organizer of SV1898 Talks - 刘诚:肿瘤免疫治疗的“淘金浪潮”

Save This Event

Event Saved